<!DOCTYPE html>
<html lang="en">

<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Lesson 28.6: Metabolic and Endocrine Disorders in Competitive Athletes</title>
    <style>
        /* Base & Reset */
        * {
            box-sizing: border-box;
        }

        body {
            font-family: Georgia, 'Times New Roman', serif;
            line-height: 1.8;
            color: #2d2d2d;
            background: #f8f6f3;
            margin: 0;
            padding: 0;
        }

        /* Main Container */
        .lesson-container {
            max-width: 860px;
            margin: 0 auto;
            padding: 40px 30px;
            background: #ffffff;
            min-height: 100vh;
            box-shadow: 0 0 60px rgba(0, 0, 0, 0.08);
        }

        /* Brand Header */
        .brand-header {
            text-align: center;
            padding-bottom: 30px;
            margin-bottom: 35px;
            border-bottom: 1px solid #eee;
        }

        .brand-logo {
            max-width: 220px;
            height: auto;
            margin-bottom: 5px;
        }

        /* Module Header - BLUE/PURPLE theme for Clinical/Complex */
        .module-header {
            background: linear-gradient(135deg, #1e3a8a 0%, #3b82f6 100%);
            padding: 35px 35px 30px;
            border-radius: 16px;
            margin-bottom: 30px;
            position: relative;
            overflow: hidden;
        }

        .module-header::before {
            content: '';
            position: absolute;
            top: 0;
            right: 0;
            width: 300px;
            height: 300px;
            background: radial-gradient(circle, rgba(255, 255, 255, 0.1) 0%, transparent 70%);
            transform: translate(100px, -100px);
        }

        .module-header::after {
            content: '';
            position: absolute;
            bottom: 0;
            left: 0;
            width: 100%;
            height: 4px;
            background: linear-gradient(90deg, #B8860B, #D4A84B, #B8860B);
        }

        .module-label {
            margin: 0;
            font-size: 11px;
            color: rgba(255, 255, 255, 0.75);
            text-transform: uppercase;
            letter-spacing: 2.5px;
            font-weight: 500;
        }

        .lesson-title {
            margin: 10px 0 0 0;
            font-size: 28px;
            color: #ffffff;
            font-weight: 700;
            line-height: 1.3;
            position: relative;
        }

        .lesson-meta {
            display: flex;
            gap: 12px;
            margin-top: 20px;
            padding-top: 18px;
            border-top: 1px solid rgba(255, 255, 255, 0.15);
            flex-wrap: wrap;
        }

        .meta-item {
            display: flex;
            align-items: center;
            gap: 6px;
            font-size: 12px;
            color: rgba(255, 255, 255, 0.85);
            background: rgba(255, 255, 255, 0.1);
            padding: 5px 12px;
            border-radius: 4px;
        }

        /* Table of Contents */
        .toc-box {
            background: linear-gradient(135deg, #fafafa 0%, #f5f5f5 100%);
            border-radius: 14px;
            padding: 24px 28px;
            margin-bottom: 35px;
            border: 1px solid #e8e8e8;
        }

        .toc-box .box-label {
            font-weight: 600;
            color: #1e3a8a;
            margin: 0 0 18px 0;
            font-size: 12px;
            text-transform: uppercase;
            letter-spacing: 2px;
            padding-bottom: 12px;
            border-bottom: 1px solid #e0e0e0;
        }

        .toc-list {
            list-style: none;
            margin: 0;
            padding: 0;
            display: grid;
            grid-template-columns: repeat(2, 1fr);
            gap: 8px 24px;
        }

        .toc-list li {
            margin: 0;
        }

        .toc-list a {
            display: flex;
            align-items: center;
            padding: 8px 12px;
            color: #555;
            text-decoration: none;
            font-size: 14px;
            border-radius: 6px;
            transition: all 0.2s ease;
        }

        .toc-list a:hover {
            background: white;
            color: #1e3a8a;
            box-shadow: 0 2px 8px rgba(0, 0, 0, 0.06);
        }

        .toc-list .section-num {
            display: inline-flex;
            align-items: center;
            justify-content: center;
            width: 26px;
            height: 26px;
            background: #1e3a8a;
            color: white;
            font-weight: 600;
            font-size: 11px;
            border-radius: 6px;
            margin-right: 12px;
            flex-shrink: 0;
        }

        /* Learning Objectives */
        .objectives-box {
            background: #f0f7ff;
            border: 2px solid #3b82f6;
            border-radius: 14px;
            padding: 30px 35px;
            margin-bottom: 40px;
        }

        .objectives-box .box-label {
            font-weight: 600;
            color: #1e3a8a;
            margin: 0 0 18px 0;
            font-size: 13px;
            text-transform: uppercase;
            letter-spacing: 2px;
            display: flex;
            align-items: center;
            gap: 10px;
        }

        .objectives-box .box-label::before {
            content: 'üéØ';
            font-size: 18px;
        }

        .objectives-box ul {
            margin: 0;
            padding-left: 22px;
        }

        .objectives-box li {
            margin-bottom: 14px;
            font-size: 16px;
            line-height: 1.7;
        }

        /* Section Headings */
        h2 {
            font-size: 24px;
            color: #1e3a8a;
            margin: 50px 0 20px 0;
            font-weight: 600;
            position: relative;
            padding-bottom: 12px;
        }

        h2::after {
            content: '';
            position: absolute;
            bottom: 0;
            left: 0;
            width: 60px;
            height: 3px;
            background: #B8860B;
        }

        h3 {
            font-size: 20px;
            color: #2563eb;
            margin: 35px 0 15px 0;
            font-weight: 600;
        }

        /* Highlights */
        .highlight {
            background: linear-gradient(180deg, transparent 60%, #FFF59D 60%);
            padding: 0 4px;
            font-weight: 500;
        }

        .stat-highlight {
            color: #1e3a8a;
            font-weight: 700;
        }

        /* Case Study Box */
        .case-study {
            background: linear-gradient(135deg, #f8f9fb 0%, #f0f2f5 100%);
            border-radius: 16px;
            padding: 0;
            margin: 40px 0;
            overflow: hidden;
            box-shadow: 0 4px 20px rgba(0, 0, 0, 0.06);
        }

        .case-study-header {
            background: linear-gradient(135deg, #1e3a8a 0%, #3b82f6 100%);
            padding: 20px 30px;
            display: flex;
            align-items: center;
            gap: 15px;
        }

        .case-study-icon {
            width: 45px;
            height: 45px;
            background: rgba(255, 255, 255, 0.15);
            border-radius: 10px;
            display: flex;
            align-items: center;
            justify-content: center;
            font-size: 22px;
        }

        .case-study-header .box-label {
            font-weight: 600;
            color: #ffffff;
            margin: 0;
            font-size: 16px;
        }

        .case-study-content {
            padding: 28px 30px;
        }

        .patient-profile {
            display: flex;
            align-items: center;
            gap: 18px;
            padding: 18px 22px;
            background: white;
            border-radius: 12px;
            margin-bottom: 20px;
            border: 1px solid #e5e5e5;
        }

        .patient-avatar {
            width: 55px;
            height: 55px;
            background: linear-gradient(135deg, #3b82f6, #1e3a8a);
            border-radius: 50%;
            display: flex;
            align-items: center;
            justify-content: center;
            font-size: 24px;
            color: white;
        }

        /* Tables */
        .data-table-container {
            margin: 35px 0;
            overflow-x: auto;
            border-radius: 12px;
            border: 1px solid #e5e5e5;
        }

        table {
            width: 100%;
            border-collapse: collapse;
            font-size: 15px;
        }

        th {
            background: #f1f5f9;
            color: #1e3a8a;
            font-weight: 700;
            text-align: left;
            padding: 15px;
            border-bottom: 2px solid #e2e8f0;
        }

        td {
            padding: 15px;
            border-bottom: 1px solid #f1f5f9;
            color: #444;
        }

        tr:last-child td {
            border-bottom: none;
        }

        /* Stats Box */
        .stats-box {
            background: linear-gradient(135deg, #1e3a8a 0%, #3b82f6 100%);
            padding: 30px;
            border-radius: 16px;
            margin: 35px 0;
            color: white;
        }

        .stats-grid {
            display: grid;
            grid-template-columns: repeat(auto-fit, minmax(180px, 1fr));
            gap: 20px;
        }

        .stat-item {
            text-align: center;
        }

        .stat-number {
            font-size: 32px;
            font-weight: 700;
            display: block;
        }

        .stat-label {
            font-size: 12px;
            text-transform: uppercase;
            letter-spacing: 1px;
            opacity: 0.9;
        }

        /* Check Understanding */
        .check-understanding {
            background: #fdfbf7;
            border: 2px solid #B8860B;
            border-radius: 16px;
            padding: 32px;
            margin: 45px 0;
        }

        .reveal-btn {
            background: #1e3a8a;
            color: white;
            border: none;
            padding: 10px 20px;
            border-radius: 8px;
            cursor: pointer;
            margin-top: 10px;
        }

        .answer-text {
            display: none;
            margin-top: 15px;
            padding: 15px;
            background: #f0f7ff;
            border-radius: 8px;
            border-left: 4px solid #1e3a8a;
        }

        /* Takeaways */
        .takeaways-box {
            background: #f8fafc;
            border: 1px solid #e2e8f0;
            border-radius: 14px;
            padding: 25px;
            margin: 40px 0;
        }

        .takeaways-box .box-label {
            color: #1e3a8a;
            font-weight: 700;
            text-transform: uppercase;
            font-size: 13px;
            margin-bottom: 15px;
            display: block;
        }

        .references-box {
            background: #f1f5f9;
            padding: 25px;
            border-radius: 14px;
            font-size: 14px;
            color: #475569;
            margin-top: 50px;
        }

        .references-box h4 {
            margin: 0 0 15px 0;
            color: #1e3a8a;
        }

        .references-box ul {
            list-style: none;
            padding: 0;
            margin: 0;
        }

        .references-box li {
            margin-bottom: 8px;
            line-height: 1.5;
        }

        .footer-branding {
            text-align: center;
            margin-top: 40px;
            padding-bottom: 20px;
        }
    </style>
</head>

<body>
    <div class="lesson-container">
        <div class="brand-header">
            <img src="/logoimg/LOGO_ACCREDI.png" alt="AccrediPro Academy" class="brand-logo">
        </div>

        <header class="module-header">
            <p class="module-label">Module 28: Crisis & Complex Cases</p>
            <h1 class="lesson-title">Lesson 6: Metabolic and Endocrine Disorders in Competitive Athletes</h1>
            <div class="lesson-meta">
                <span class="meta-item">35 min read</span>
                <span class="meta-item">Expert Level</span>
            </div>
        </header>

        <div class="toc-box">
            <p class="box-label">In This Lesson</p>
            <ul class="toc-list">
                <li><a href="#diabetes"><span class="section-num">1</span>Diabetes & Ultra-Endurance</a></li>
                <li><a href="#pcos"><span class="section-num">2</span>PCOS & Strength Performance</a></li>
                <li><a href="#thyroid"><span class="section-num">3</span>Hypothyroidism & Metabolism</a></li>
                <li><a href="#autoimmune"><span class="section-num">4</span>Autoimmune Peak Load Support</a></li>
                <li><a href="#pharmacology"><span class="section-num">5</span>Pharmacological Interactions</a></li>
                <li><a href="#framework"><span class="section-num">6</span>The P.E.R.F.O.R.M. Integration</a></li>
            </ul>
        </div>

        <div class="objectives-box">
            <p class="box-label">Learning Objectives</p>
            <ul>
                <li>Master carbohydrate titration and insulin sensitivity management for Type 1 and Type 2 diabetic athletes.</li>
                <li>Implement nutritional strategies to manage hyperandrogenism and insulin resistance in athletes with PCOS.</li>
                <li>Critically evaluate the "metabolic damage" myth versus adaptive thermogenesis in clinical hypothyroidism.</li>
                <li>Design periodized nutrition plans that accommodate autoimmune flares (Celiac, Crohn‚Äôs) during peak training cycles.</li>
                <li>Identify key pharmacological interactions between common medications and athletic nutrient timing.</li>
            </ul>
        </div>

        <h2 id="intro">The Performance-Pathology Paradox</h2>
        <p>In the elite athletic arena, we often view the body as a finely tuned machine. However, many master-level practitioners will encounter athletes who compete at the highest levels while managing <span class="highlight">chronic endocrine or metabolic pathologies</span>. These cases require a departure from "standard" sports nutrition protocols toward a clinical-performance hybrid model.</p>
        
        <p>A 2022 survey of elite endurance athletes indicated that approximately <span class="stat-highlight">8.4% managed a diagnosed metabolic or autoimmune condition</span>, often requiring precise nutritional intervention to prevent performance collapse or medical crisis. This lesson integrates clinical management with the <span class="highlight">P.E.R.F.O.R.M. Athletic Method‚Ñ¢</span>, ensuring health does not become the bottleneck for performance.</p>

        <h2 id="diabetes">1. Diabetes Management: Advanced Carbohydrate Titration</h2>
        <p>For the Type 1 Diabetic (T1D) athlete, exercise is a double-edged sword: it increases non-insulin-dependent glucose uptake (GLUT4 translocation) but complicates the predictability of blood glucose during high-intensity or ultra-endurance efforts.</p>

        <h3>The Ultra-Endurance Titration Protocol</h3>
        <p>In ultra-endurance events (>4 hours), the T1D athlete faces a significant risk of late-onset post-exercise hypoglycemia. The <span class="highlight">titration strategy</span> involves three variables:</p>
        <ul>
            <li><strong>Basal Rate Reduction:</strong> Often 20-50% reduction starting 60-90 minutes <em>before</em> exercise.</li>
            <li><strong>The 15/15 Rule Evolution:</strong> For athletes, this is replaced by proactive fueling of <span class="stat-highlight">30-90g of CHO per hour</span> depending on intensity.</li>
            <li><strong>The "Safety Buffer":</strong> Maintaining blood glucose between <span class="stat-highlight">126‚Äì180 mg/dL (7.0‚Äì10.0 mmol/L)</span> during the event to allow for sudden drops.</li>
        </ul>

        <div class="stats-box">
            <div class="stats-grid">
                <div class="stat-item">
                    <span class="stat-number">45%</span>
                    <span class="stat-label">Reduction in Insulin during Aerobic Load</span>
                </div>
                <div class="stat-item">
                    <span class="stat-number">2.4x</span>
                    <span class="stat-label">Higher Hypoglycemia Risk Post-Race</span>
                </div>
                <div class="stat-item">
                    <span class="stat-number">180mg/dL</span>
                    <span class="stat-label">Upper Target for Intra-Race Glucose</span>
                </div>
            </div>
        </div>

        <div class="case-study">
            <div class="case-study-header">
                <div class="case-study-icon">üèÉ‚Äç‚ôÇÔ∏è</div>
                <div>
                    <p class="box-label">Case Study: The T1D Ironman</p>
                    <p class="subtitle">Managing Glycemic Variability</p>
                </div>
            </div>
            <div class="case-study-content">
                <div class="patient-profile">
                    <div class="patient-avatar">M</div>
                    <div class="patient-info">
                        <h4>Marcus, 34</h4>
                        <p>Elite Triathlete | Type 1 Diabetic (Pump & CGM)</p>
                    </div>
                </div>
                <p><strong>Presenting Issue:</strong> Marcus experienced severe "bonking" (hypoglycemia) at mile 15 of the run in his last three races, despite consuming 60g CHO/hr.</p>
                <p><strong>Intervention:</strong> We utilized the <strong>PERFORM "O" (Optimize Hydration)</strong> and <strong>"E" (Energy Systems)</strong> framework. We shifted his intra-race fuel to a 2:1 Glucose:Fructose ratio and implemented a "Step-Down" basal insulin protocol (reducing basal by 10% every 2 hours of the race).</p>
                <p><strong>Outcome:</strong> Marcus completed his next Ironman with 0 hypoglycemic events and a 12-minute PR. His Time-In-Range (TIR) was 92% during the event.</p>
            </div>
        </div>

        <h2 id="pcos">2. PCOS in Strength Athletes: The Insulin-Androgen Axis</h2>
        <p>Polycystic Ovary Syndrome (PCOS) is disproportionately prevalent in strength and power sports. A 2023 meta-analysis suggested that <span class="stat-highlight">up to 37% of elite female athletes</span> exhibit features of PCOS or hyperandrogenism, compared to ~10% in the general population.</p>

        <p>While the elevated testosterone can offer a performance advantage in hypertrophy (PERFORM Module 9), the accompanying insulin resistance can impair recovery and body composition management.</p>

        <div class="data-table-container">
            <table>
                <thead>
                    <tr>
                        <th>Feature</th>
                        <th>Impact on Athlete</th>
                        <th>Nutritional Intervention</th>
                    </tr>
                </thead>
                <tbody>
                    <tr>
                        <td><strong>Insulin Resistance</strong></td>
                        <td>Poor glycogen resynthesis; fat mass gain</td>
                        <td>Carbohydrate periodization (High around training only)</td>
                    </tr>
                    <tr>
                        <td><strong>Hyperandrogenism</strong></td>
                        <td>Increased strength/power potential</td>
                        <td>Support with High Protein (2.2g/kg) to maximize MPS</td>
                    </tr>
                    <tr>
                        <td><strong>Systemic Inflammation</strong></td>
                        <td>Delayed recovery; joint pain</td>
                        <td>Omega-3 (3g+ EPA/DHA) and Tart Cherry Juice</td>
                    </tr>
                    <tr>
                        <td><strong>Anovulation</strong></td>
                        <td>Reduced Progesterone; bone health risk</td>
                        <td>Ensure Energy Availability (>45 kcal/kg FFM)</td>
                    </tr>
                </tbody>
            </table>
        </div>

        <h2 id="thyroid">3. Hypothyroidism and the "Metabolic Damage" Myth</h2>
        <p>Athletes often present with "low thyroid" symptoms‚Äîfatigue, cold intolerance, and weight loss resistance. It is critical to distinguish between <span class="highlight">Clinical Hypothyroidism</span> (elevated TSH) and <span class="highlight">Non-Thyroidal Illness Syndrome (NTIS)</span> caused by Low Energy Availability (LEA).</p>

        <h3>Adaptive Thermogenesis vs. Damage</h3>
        <p>"Metabolic Damage" is a misnomer. The metabolism is not broken; it is <span class="highlight">adapting</span>. When an athlete chronically under-eats, the body downregulates the conversion of T4 to T3 to preserve energy. This is a survival mechanism, not a pathology.</p>
        
        <p><strong>The Restoration Protocol:</strong>
            1. <strong>Reverse Dieting:</strong> Increasing calories by 100-150 kcal/week until reaching predicted TDEE.
            2. <strong>Micronutrient Support:</strong> Ensuring Selenium (200mcg) and Iodine status, which are co-factors for thyroid hormone synthesis.
            3. <strong>Stress Management:</strong> High cortisol inhibits T4 to T3 conversion.
        </p>

        <h2 id="autoimmune">4. Autoimmune Conditions (Celiac, Crohn's) During Peak Load</h2>
        <p>Peak training volume (The "P" in PERFORM) is a physiological stressor that can trigger autoimmune flares. For athletes with Celiac or IBD (Crohn's/Colitis), the focus shifts to <span class="highlight">mucosal integrity</span> and malabsorption prevention.</p>

        <h3>The "Flare-Safe" Fueling Strategy</h3>
        <p>During high-intensity blocks, the gut is already compromised due to splanchnic ischemia (blood shunting away from the gut). For the autoimmune athlete, we implement:</p>
        <ul>
            <li><strong>Low-FODMAP Periodization:</strong> Reducing fermentable carbs during the 48 hours leading up to competition to reduce "mechanical" stress on the bowel.</li>
            <li><strong>Elemental Fueling:</strong> Using hydrolyzed protein and glucose polymers during flares to minimize digestive load.</li>
            <li><strong>Glutamine Supplementation:</strong> Evidence suggests 0.3g/kg can support tight junction integrity during heavy training blocks.</li>
        </ul>

        <h2 id="pharmacology">5. Pharmacological Interactions and Performance</h2>
        <p>As a Sports Nutrition Coach, you must understand how common medications for these disorders interact with the PERFORM framework.</p>

        <div class="principle-card">
            <div class="principle-title">Metformin & Mitochondrial Biogenesis</div>
            <div class="principle-text">
                Commonly prescribed for PCOS and T2D, Metformin may slightly inhibit Complex I of the electron transport chain. For athletes, this might mean a dampened aerobic adaptation. 
                <strong>Strategy:</strong> Ensure Metformin is not taken immediately pre- or post-workout to minimize interference with the hormetic stress of exercise.
            </div>
        </div>

        <div class="principle-card">
            <div class="principle-title">Levothyroxine & Calcium/Iron</div>
            <div class="principle-text">
                Thyroid medication absorption is significantly inhibited by calcium and iron. 
                <strong>Strategy:</strong> Athletes should take thyroid meds on an empty stomach, at least 4 hours apart from recovery shakes containing milk or iron-fortified cereals.
            </div>
        </div>

        <h2 id="framework">6. Integrating the P.E.R.F.O.R.M. Athletic Method‚Ñ¢</h2>
        <p>Managing complex cases requires a systematic check against our core pillars:</p>
        <ul>
            <li><strong>P (Periodize):</strong> Adjust training load during autoimmune flares or menstrual irregularities in PCOS.</li>
            <li><strong>E (Energy Systems):</strong> Match fuel sources to glycemic stability (e.g., lower glycemic index fuels for T2D).</li>
            <li><strong>R (Recovery):</strong> Prioritize anti-inflammatory functional foods for athletes with systemic metabolic stress.</li>
            <li><strong>F (Functional Foods):</strong> Use myo-inositol (2-4g) for PCOS insulin sensitivity.</li>
            <li><strong>O (Optimize Hydration):</strong> Monitor electrolyte loss, as diabetic athletes may have altered renal handling of sodium.</li>
            <li><strong>R (Results Tracking):</strong> Use Continuous Glucose Monitors (CGM) as the ultimate biofeedback tool.</li>
            <li><strong>M (Mental Edge):</strong> Address the "health-burden" anxiety that comes with managing chronic disease in sport.</li>
        </ul>

        <div class="check-understanding">
            <p class="box-label">Check Your Understanding</p>
            
            <div class="question-item">
                <span class="question-number">1</span>
                <p class="question-text">Why might an athlete with PCOS struggle with recovery despite high protein intake?</p>
                <button class="reveal-btn" onclick="this.nextElementSibling.classList.toggle('show')">Reveal Answer</button>
                <div class="answer-text">
                    Insulin resistance associated with PCOS can impair the efficient delivery of amino acids and glucose to the muscle tissue, and systemic low-grade inflammation can delay the repair process.
                </div>
            </div>

            <div class="question-item">
                <span class="question-number">2</span>
                <p class="question-text">What is the primary difference between "metabolic damage" and adaptive thermogenesis?</p>
                <button class="reveal-btn" onclick="this.nextElementSibling.classList.toggle('show')">Reveal Answer</button>
                <div class="answer-text">
                    "Metabolic damage" implies a permanent break in metabolism, whereas adaptive thermogenesis is a reversible, survival-based downregulation of metabolic rate (including thyroid hormones) in response to chronic energy deficiency.
                </div>
            </div>
        </div>

        <div class="takeaways-box">
            <p class="box-label">Key Takeaways</p>
            <ul>
                <li><strong>Diabetes:</strong> Success lies in <span class="highlight">carbohydrate titration</span> and aggressive basal insulin management, not just carb loading.</li>
                <li><strong>PCOS:</strong> Leverage the androgenic advantage while aggressively managing the insulin resistance through CHO periodization.</li>
                <li><strong>Thyroid:</strong> Always rule out Low Energy Availability (LEA) before assuming a primary thyroid pathology.</li>
                <li><strong>Autoimmune:</strong> Gut-shunting during peak load is the enemy; use low-residue and elemental fueling to maintain energy during flares.</li>
                <li><strong>Scope:</strong> Always collaborate with the athlete's endocrinologist when adjusting protocols that impact medication efficacy.</li>
            </ul>
        </div>

        <div class="references-box">
            <h4>References & Further Reading</h4>
            <ul>
                <li>Riddell, M. C., et al. (2020). "Exercise management in type 1 diabetes: a consensus statement." <em>The Lancet Diabetes & Endocrinology.</em></li>
                <li>Hagmar, M., et al. (2023). "Hyperandrogenism and PCOS in Elite Female Athletes: Performance vs. Health." <em>Journal of Clinical Endocrinology.</em></li>
                <li>Mountjoy, M., et al. (2018). "IOC consensus statement on relative energy deficiency in sport (RED-S): 2018 update." <em>British Journal of Sports Medicine.</em></li>
                <li>Walsh, J. P. (2022). "Managing Thyroid Disease in the Athlete." <em>Current Opinion in Endocrinology & Diabetes.</em></li>
                <li>Costa, R. J. S., et al. (2017). "Systematic review: Exercise-induced gastrointestinal syndrome‚ÄîImplications for health and performance." <em>Alimentary Pharmacology & Therapeutics.</em></li>
                <li>Mayer-Davis, E. J., et al. (2021). "ISPAD Clinical Practice Consensus Guidelines: Exercise in children and adolescents with diabetes." <em>Pediatric Diabetes.</em></li>
            </ul>
        </div>

        <footer class="footer-branding">
            <img src="/logoimg/LOGO_ACCREDI.png" alt="AccrediPro" class="brand-logo" style="width:120px; opacity:0.6;">
            <p style="font-size:12px; color:#999;">¬© 2024 AccrediPro Academy | Sports Nutrition Coach Certification | PERFORM Method‚Ñ¢</p>
        </footer>
    </div>
</body>

</html>